Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen Fei

Showing results (681-690 of 709) with videos related to

Pageof 71
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 29, 2020
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench studyKeng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
Microbiome|May 17, 2025
Tissue-resident microbiota signature in nasopharyngeal carcinomaXi-Rong Tan, Han Qiao, Ying-Qing Li, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan-Ping Mao, Shun-Xin Wang, Tian-Sheng Gao, et al.
Molecular Cancer|January 12, 2021
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responsesYu-Pei Chen, Jia-Wei Lv, Yan-Ping Mao, et al.
The Lancet. Oncology|June 3, 2023
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysisClaire Petit, Anne Lee, Jun Ma, et al.
Orthopaedic Surgery|June 8, 2018
Complications and Prevention Strategies of Oblique Lateral Interbody Fusion TechniqueZhong-You Zeng, Zhao-Wan Xu, Deng-Wei He, et al.
Cancer Cell|February 28, 2025
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialCheng Xu, Guan-Qun Zhou, Wen-Fei Li, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
Vaccine|December 7, 2010
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humansJiang Wu, Xiang Zhong, Chris Ka-fai Li, et al.
Pageof 71

Showing results (681-690 of 709) with videos related to

Sort By:
Pageof 71
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 29, 2020
A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench studyKeng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, et al.
JAMA|August 23, 2022
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical TrialLing-Long Tang, Rui Guo, Ning Zhang, et al.
Microbiome|May 17, 2025
Tissue-resident microbiota signature in nasopharyngeal carcinomaXi-Rong Tan, Han Qiao, Ying-Qing Li, et al.
BMJ (Clinical Research Ed.)|February 6, 2023
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trialYan-Ping Mao, Shun-Xin Wang, Tian-Sheng Gao, et al.
Molecular Cancer|January 12, 2021
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responsesYu-Pei Chen, Jia-Wei Lv, Yan-Ping Mao, et al.
The Lancet. Oncology|June 3, 2023
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysisClaire Petit, Anne Lee, Jun Ma, et al.
Orthopaedic Surgery|June 8, 2018
Complications and Prevention Strategies of Oblique Lateral Interbody Fusion TechniqueZhong-You Zeng, Zhao-Wan Xu, Deng-Wei He, et al.
Cancer Cell|February 28, 2025
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialCheng Xu, Guan-Qun Zhou, Wen-Fei Li, et al.
Journal of the National Cancer Institute|October 23, 2020
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaYuan Lei, Ying-Qin Li, Wei Jiang, et al.
Vaccine|December 7, 2010
Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humansJiang Wu, Xiang Zhong, Chris Ka-fai Li, et al.
Pageof 71